Real Implication of Fertility-Sparing Surgery for Ovarian Cancer: Reproductive Outcomes.

fertility ovarian cancer pregnancy

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
03 Jul 2024
Historique:
received: 26 04 2024
revised: 30 06 2024
accepted: 02 07 2024
medline: 13 7 2024
pubmed: 13 7 2024
entrez: 13 7 2024
Statut: epublish

Résumé

to prove the effectivity of fertility-sparing procedures in early-stage ovarian cancer by assessing pregnancy rates and obstetrical outcomes. we performed a retrospective multicenter study among 55 Spanish hospitals, collecting patients from 18 to 40 years old with diagnosis of early-stage ovarian cancer, epithelial (EOC) or non-epithelial (non-EOC), from January 2010 to December 2019. Data on the use of assisted reproductive techniques, pregnancy attempts and obstetrical outcomes were collected. a total of 150 patients met inclusion criteria, 70 (46.6%) EOC and 80 (53.4%) non-EOC. Pregnancy attempts were reported in 51 (34%) patients, with 42 (28%) patients carrying the pregnancy to term. Among them, 30 (71.4%) underwent surgery alone and 12 (28.6%) had additional postoperative chemotherapy. A total of 32 (76.1% patients) had spontaneous pregnancies and 10 (23.9%) required in vitro fertilization. There was only one (2.4%) complication reported. Vaginal delivery was reported in twenty-nine (69%) patients and cesarean section in five (11.9%) patients. fertility-sparing management for ovarian cancer seems to be an option with proven good pregnancy rates and low complications. The selection of patients must consider strict criteria in order to maintain a good prognosis.

Sections du résumé

BACKGROUND BACKGROUND
to prove the effectivity of fertility-sparing procedures in early-stage ovarian cancer by assessing pregnancy rates and obstetrical outcomes.
METHODS METHODS
we performed a retrospective multicenter study among 55 Spanish hospitals, collecting patients from 18 to 40 years old with diagnosis of early-stage ovarian cancer, epithelial (EOC) or non-epithelial (non-EOC), from January 2010 to December 2019. Data on the use of assisted reproductive techniques, pregnancy attempts and obstetrical outcomes were collected.
RESULTS RESULTS
a total of 150 patients met inclusion criteria, 70 (46.6%) EOC and 80 (53.4%) non-EOC. Pregnancy attempts were reported in 51 (34%) patients, with 42 (28%) patients carrying the pregnancy to term. Among them, 30 (71.4%) underwent surgery alone and 12 (28.6%) had additional postoperative chemotherapy. A total of 32 (76.1% patients) had spontaneous pregnancies and 10 (23.9%) required in vitro fertilization. There was only one (2.4%) complication reported. Vaginal delivery was reported in twenty-nine (69%) patients and cesarean section in five (11.9%) patients.
CONCLUSIONS CONCLUSIONS
fertility-sparing management for ovarian cancer seems to be an option with proven good pregnancy rates and low complications. The selection of patients must consider strict criteria in order to maintain a good prognosis.

Identifiants

pubmed: 39001314
pii: diagnostics14131424
doi: 10.3390/diagnostics14131424
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Marta Heras (M)

Gynecology Department, Hospital Universitario Santa Cristina, 28009 Madrid, Spain.

Maria Alonso-Espias (M)

Gynecologic Oncology Unit, La Paz University Hospital, 28046 Madrid, Spain.

Octavio Arencibia (O)

Gynecology Department, Hospital Universitario Materno Infantil, 06010 Las Palmas de Gran Canaria, Spain.

Lucas Minig (L)

Gynecology Department, IMED Hospitales, 46100 Valencia, Spain.

Lola Marti (L)

Gynecology Department, Hospital Universitario Bellvitge, 08907 Barcelona, Spain.

Maria Dolores Diestro (MD)

Gynecologic Oncology Unit, La Paz University Hospital, 28046 Madrid, Spain.

Juan Cespedes (J)

Gynecology Department, Hospital Universitario de Donostia, 20014 San Sebastian, Spain.

Isabel Niguez (I)

Gynecology Department, Hospital Virgen de la Arrixaca, 30120 Murcia, Spain.

Blanca Gil-Ibañez (B)

Gynecology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.

Berta Diaz-Feijoo (B)

Institute Clinic of Gynecology, Obstetrics and Neotatology, Hospital Clinic de Barcelona, 08007 Barcelona, Spain.

Antoni Llueca (A)

Gynecology Department, Hospital de Castellón, 12004 Castellón, Spain.

Claudia Rosado (C)

Gynecology Department, Hospital de Mataró, 08304 Barcelona, Spain.

Sara Iacoponi (S)

Gynecology Department, Hospital Quirón Madrid, 28223 Madrid, Spain.

Carlos Lopez de la Manzanara (C)

Gynecology Department, Hospital General Universitario de Ciudad Real, 13005 Ciudad Real, Spain.

Sara Morales (S)

Gynecology Department, Hospital Universitario Infanta Leonor, 28031 Madrid, Spain.

Maria Jose Fernandez-Galguera (MJ)

Gynecology Department, Complejo Asistencial de Zamora, 49022 Zamora, Spain.

Ana Cano (A)

Gynecology Department, Hospital Universitario Fundación Alcorcón, 28922 Madrid, Spain.

Mikel Gorostidi (M)

Gynecology Department, Hospital Universitario de Donostia, 20014 San Sebastian, Spain.

Ignacio Zapardiel (I)

Gynecologic Oncology Unit, La Paz University Hospital, 28046 Madrid, Spain.

Classifications MeSH